We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Max
I doesn’t look like we were mentioned but no actual video or transcript.
https://cloud.withgoogle.com/next/session-library?filters=track-ai-and-ml&demo=SCT-AI1#all
Totally agree about Zero, it is about time we heard about the resubmission. It seems to have gone very quiet on announcements at the moment. Maybe a blockbuster announcement with the yearly results? We can all dream.
Thanks
Https://www.linkedin.com/posts/bayer-pharmaceuticals_radiology-bayerinradiology-ai-activity-7185607838898008064-dNqV?utm_source=share&utm_medium=member_ios
Looks like quite a show put on here maybe our tech has had a mention .
Cautious
Totally agree we are at this sp due to all the shenanigans but what I am trying to say is there must be an exit strategy by TB and no way is that at this valuation. He must know more about what is in the pipeline. As I keep saying this company must be or will be on bigger fish’s radar. TB is looking at a paper loss of £10m from what was the high point of 20p+. I think we have to be looking at a figure above that for him to sell.
Regarding KS and her involvement in other trials. It doesn’t mention IB but I would guess that they are using our technology for the imagery. The more other universities use our technology the better. Keep spreading the word etc.
Thanks
Could not agree more Cautious, I have no confidence in the board.
Anyway this might be of interest to those following the research work. Kathleen Schmainda is involved in a clinical trial. Interesting is no mention of IB, just MCW.
Here is the link. If you search for eaf223/gable and filter the results to the last week you get a few results with quite a lot of detail. It does fit in to one of the video presentations when they were discussing future work.
https://blog-ecog-acrin.org/now-enrolling-eaf223-gable-for-patients-with-glioblastoma/
The clinical trial reference is NCT06319027.
Financial results should be week after next, looking forward to seeing the figures.
Have a good weekend all
Shrek
Tyke the only reason the share price is were it is, is because TB ran it down to line his pockets, nothing to do with the quality of the company. He can come up with as many excuses has he wants but the truth is he his a manipulative little w.nker who is only interested in his own pocket and doesn’t give a f.ck about pi’s. That said he can only keep a good company down for so long, eventually the qualility will come through
Thank you Tyke68 for sharing relevant information; my thanks also to others, who continuously do the same on this forum.
I have, foolishly as it turns out, held my IQAI investment, through thick and thin, for over two years. I have since realised that any company managed by Mr. Brown is optimal for traders rather than LTIs.
Nevertheless, in this case the products, and quality of technology, upon which the investment case rests is sound enough. The negative side is that competitors are presumably developing similar AI led scanning technology?
My aspiration rests on a major entity deciding to make an offer for the company. In my case 30p would be more than sufficient to realise a very good profit, although I appreciate that potentially, the value created by IB should command a significantly higher buyout offer.
GLALTIs.
More progress on MRI scans
https://apple.news/AoK71NEeqTkeqUICCUtt_ug
Thanks
Max
A nice bidding war for our technology between Google, Microsoft, Elon Musk and anybody else would be quite nice. I wonder if TB has their direct numbers. I think we could all retire nicely then.
Thanks
Fingers crossed Tyke !
Could do with some good news
Max
Not sure if this is positive or negative?
Negative, Google supersede our technology?
Positive, Google helps with our AI or they buy our AI?
Watch this space
Thanks
Hopefully when we get the results by the end of the month we will know if Bayer or GEHC customers are actually using our technology.
Thanks
If they received the information they should announce it immediately or immediately after the end of the trading session
Its either ISA trades
or...something big to be RNS'd on Monday
was that a ramp...oh yes....
just a little one
Nice to see the rise here today, only need another 10.00 a share and I’ve broken even 🙄
Agree Tyke, us LTH's have always believed in the Tech,hopefully no more off field shenanigans for a while and we get a sensible re rate which reflects the true potential and value of the company. Have a good weekend all and just hope normality returns soon.
Looks like someone filled their ISA SIPP on last day of year.
Nice buy
Wondered why it was moving up with small trades
Showing
Yet again the science is there just not the company valuation. At some point somebody from Bayer, GEHC, Siemens etc must see the value in our technology. That would help pay for the drug trials
Or TB sells everything and lives a life of more luxury and we follow in his footsteps
“In IB we trust”
Thanks, have a good weekend everybody
Sorry Kaneonaim
My phone updated after I posted